IONS IONIS PHARMACEUTICALS INC Product Launches 8-K Filing 2023 - FDA Approval Ionis Pharmaceuticals announced that its partner, Biogen, has received FDA approval for the treatment of ALS in adults with a specific gene mutation.Get access to all SEC 8-K filings of the IONIS PHARMACEUTICALS INC